课题基金 / 基金详情

Reversing senescence and exhaustion signalling pathways in primary human T lymphocytes during ageing

Reversing senescence and exhaustion signalling pathways in primary human T lymphocytes during ageing
逆转衰老过程中人原代 T 淋巴细胞的衰老和耗竭信号通路
批准号:
BB/J006750/1
负责人:
Arne Akbar
金额:
$59.81万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2012
资助国家:
英国
项目状态:
已结题
起止时间:
2012 至 --

项目摘要

项目成果

Arne Akbar的其他基金

相似基金

相关文献

中文摘要
翻译
免疫系统的效力不应被重新评估。如果没有有效的免疫力,我们的身体将在几天内变成腐烂的身体。然而,这种针对入侵微生物的有效防御必须得到有效控制,因为如果我们的免疫系统转向对我们自己不利,将会产生可怕的后果。有两个控制免疫力的过程,第一个是称为衰竭的过程,在这个过程中,被称为T淋巴细胞的白细胞过度激活,导致其功能活动的丧失。这是通过在T细胞表面结合表面蛋白来实现的,这种蛋白可以抑制毒素的产生,从而适当地杀死微生物,并防止它们的增殖。因此,疲劳是通过细胞表面抑制受体的信号来调节的。其次,T淋巴细胞的反复刺激导致其复制能力的丧失,这是由于由DNA组成的染色体末端的特殊结构的丢失,该结构被称为端粒。端粒的过度丢失启动了信号通路,该通路感知DNA损伤,从而关闭细胞的增殖能力。这个过程被称为衰老,与疲惫不同,它是由细胞核中受损的DNA发出的信号启动的。随着我们年龄的增长(70岁),我们变得更容易受到感染,即使是我们年轻时免疫的那些感染。这表明,免疫系统变得过于脆弱,无法完全有效地防止微生物对我们身体的终身攻击。然而,从老年人身上分离的T淋巴细胞(白细胞)功能失调的原因尚不清楚。众所周知,老年人的T淋巴细胞具有衰老细胞的特征,但目前还不知道它们是否也会耗尽。我们最近发现,在年轻人(40岁)中,我们可以阻止细胞中调节衰老的蛋白质或细胞表面调节疲劳的蛋白质以增强其功能。关键的问题是,我们是否可以通过阻断衰老途径、疲惫途径或两者兼而有之来提高老年人T淋巴细胞的功能。这是一个重要的目标,因为人类的人口结构正在向免疫缺陷的老年转变,这导致感染和恶性肿瘤的增加。因此,主要目的是:1)调查老年人T淋巴细胞中衰老和衰竭控制元件的表达。2)确定在老年人血液中增加的称为细胞因子的活性介质是否可以开启衰老或衰竭途径。3)调查我们是否可以使用特定的抑制剂来阻止老年人T细胞的衰老或衰竭,以增强其功能和增殖能力(我们最近表明,这可以在年轻人中做到)。4)调查阻断衰老或衰竭信号是否可以增加老年人T细胞的功能活性,这种T细胞是巨细胞病毒所特有的,看起来是衰老的,或引起带状疱疹的水痘带状疱疹病毒,这种病毒在老年人中的发病率增加。所有这些工作都将在直接从老年人血液中获得的白细胞上进行,因此与提高人类衰老过程中发生的免疫缺陷的能力直接相关。
英文摘要
The potency of the immune system should not be undrestimated. Without effective immunity our bodies would turn into rotting carcasses within a few days. However, such a potent defense against invading microorganisms has to be effectively controlled as there would be dire consequences if our immune systems turns against ourselves. There are two processes that control immunity the first is a process called exhaustion, where the over activation of white blood cells known as T lymphocytes leads to loss of their functional activity. This is achieved through binding of surface proteins on the T cell surface that inhibit the production of toxins that kill microorganisms properly and also prevent their proliferation. Exhaustion is therefore regulated by the signalling through cell surface inhibitory receptors. Secondly, the repeated stimulation of T lymphocytes leads to the loss of their replicative capacity and this is due to the loss of specialized structures at the end of chromosomes that are made of DNA and are known as telomeres. Excessive loss of telomeres initiates signalling pathways that sense DNA damage that turn off the capacity of the cell to proliferate. This process is known as senescence and unlike exhaustion, is initiated by signals from damaged DNA in the nucleus.As we get older (>70 years), we become more susceptible to infections, even those to which we were immune in our youth. This indicates that the immune system becomes too fragile to be fully effective in preventing the lifelong assault on our bodies by micro-organisms. However the reasons why the T lymphocytes (white cells) isolated from old individuals are dysfunctional is not known. It is well recognized that the T lymphocytes from older humans have characteristics of senescent cells however it is not know if they may also be exhausted. We have recently found that in young individuals (<40 years), we can block proteins in the cell that regulate senescence or proteins on the cell surface that regulate exhaustion to increase their function. The key question is whether we can boost the function of T lymphocytes from older humans by blocking senescence pathways, exhaustion pathways or both. This is an important goal given the demographic shift of humans towards an older age with defective immunity that leads to increases of infection and malignancy. The main aims therefore are:1) To investigate the expression of senescence and exhaustion control elements in the T lymphocytes of older humans.2) To determine whether active mediators called cytokines that are increased in the blood of older humans can turn on senescence or exhaustion pathways.3) To investigate if we can block senescence or exhaustion in T cells from older humans using specific inhibitors to boost their function and capacity to proliferate (we have shown recently that this can be done in young subjects).4) To investigate whether blocking senescence or exhaustion signalling can increase the functional activity of T cells of older humans that are specific for cytomegalovirus, that appear senescent, or varicella zoster virus that causes shingles, the incidence of which is increased in older humans.All this work will be performed on leucocytes that are obtained directly from the blood of older humans and therefore has directly relevance for the ability to boost the defective immunity that occurs during ageing in humans.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1111/cei.12876
发表时间: 2017-01
期刊: Clinical and experimental immunology
影响因子: 4.6
作者: [Akbar AN]
通讯作者: Akbar AN
DOI: 10.1038/ni.2981
发表时间: 2014-10
期刊: Nature immunology
影响因子: 30.5
作者: []
通讯作者:
Mechanism for CD8+ T cell recognition and removal of senescent tissue cells during ageing
  • 批准号:
    BB/Y003365/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $102.14万
  • 财政年份:
    2024
  • 负责人:
    Arne Akbar
  • 依托单位:
Establishing a network to catalyse collaboration for reducing immune ageing (CARINA: CAtalyst Reducing ImmuNe Ageing)
  • 批准号:
    BB/W018225/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $39.64万
  • 财政年份:
    2022
  • 负责人:
    Arne Akbar
  • 依托单位:
How does blocking inflammation enhance human cutaneous immunity during ageing in vivo?
  • 批准号:
    MR/T030534/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $109.01万
  • 财政年份:
    2020
  • 负责人:
    Arne Akbar
  • 依托单位:
Senescent CD8+ T and NK cells contribute to immunopathogy duting cutaneous leishmaniasis
  • 批准号:
    MR/T015853/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $93.31万
  • 财政年份:
    2020
  • 负责人:
    Arne Akbar
  • 依托单位:
国内基金
海外基金
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
  • 批准号:
    82371634
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵福军
  • 依托单位:
PAX5调控LINE-1转录影响细胞衰老的机制研究
  • 批准号:
    32200603
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2022
  • 负责人:
    张伟娜
  • 依托单位:
长寿基因SIRT7调控核苷酸切除修复通路的机制研究
  • 批准号:
    32100605
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    耿安珂
  • 依托单位:
雄性线虫特异分泌蛋白F56D2.8调节衰老与寿命的机制研究
  • 批准号:
    32100604
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    龚健科
  • 依托单位: